Ryusei Matsuyama Selected Research

Ryusei Matsuyama Research Topics

Disease

65	Neoplasms (Cancer) 01/2024 - 02/2006
26	Neoplasm Metastasis (Metastasis) 02/2024 - 02/2006
24	Pancreatic Neoplasms (Pancreatic Cancer) 04/2023 - 05/2007
12	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2020
11	Adenocarcinoma 02/2021 - 05/2007
8	Inflammation (Inflammations) 01/2024 - 04/2015
8	Lymphatic Metastasis 04/2023 - 08/2016
6	Klatskin Tumor 06/2024 - 05/2012
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2006
5	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2023 - 02/2015
5	Cholangiocarcinoma 02/2023 - 08/2019
5	Hepatocellular Carcinoma (Hepatoma) 02/2023 - 12/2013
5	Cholangitis 07/2021 - 05/2013
5	Liver Failure 05/2020 - 11/2007
5	Ewing Sarcoma (Sarcoma, Ewing) 01/2019 - 07/2016
4	Triple Negative Breast Neoplasms 05/2021 - 09/2020
4	Infections 02/2016 - 10/2013
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 01/2014
3	Pathologic Constriction (Stenosis) 04/2016 - 12/2012
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2023 - 12/2020
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2021 - 01/2017
2	Sepsis (Septicemia) 03/2021 - 10/2013
2	Gallbladder Neoplasms (Gallbladder Cancer) 03/2021 - 03/2021
2	Colonic Neoplasms (Colon Cancer) 12/2020 - 07/2006
2	Hemorrhage 05/2020 - 12/2015
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2018 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 03/2016 - 01/2015
2	Carcinoma (Carcinomatosis) 05/2008 - 05/2007
1	Papillary Adenocarcinoma 03/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 12/2021

Drug/Important Bio-Agent (IBA)

14	Gemcitabine FDA Link 04/2023 - 05/2007
13	Biomarkers (Surrogate Marker)IBA 02/2022 - 02/2017
10	Proteins (Proteins, Gene)FDA Link 02/2022 - 05/2008
9	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 03/2016
5	InterferonsIBA 07/2022 - 12/2013
5	Methionine (L-Methionine)FDA Link 04/2022 - 11/2020
4	Oxygen (Dioxygen)IBA 07/2022 - 05/2012
4	L-methionine gamma-lyaseIBA 01/2022 - 01/2018
4	palbociclibIBA 01/2021 - 07/2016
3	Histones (Histone)IBA 04/2022 - 12/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 05/2008
3	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2017
3	PlasticsIBA 12/2020 - 02/2015
3	Docetaxel (Taxotere)FDA Link 09/2019 - 11/2017
3	pazopanib FDA Link 01/2019 - 01/2015
2	Carcinoembryonic AntigenIBA 01/2024 - 07/2022
2	Complement System Proteins (Complement)IBA 07/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 07/2022 - 01/2021
2	Mechanistic Target of Rapamycin Complex 1IBA 07/2022 - 01/2021
2	Lysine (L-Lysine)FDA Link 04/2022 - 01/2022
2	BismuthIBA 04/2022 - 12/2012
2	Semaphorin-3AIBA 02/2022 - 12/2013
2	BilirubinIBA 08/2021 - 08/2019
2	SolutionsIBA 02/2021 - 01/2020
2	AntigensIBA 02/2021 - 11/2020
2	Immune Checkpoint ProteinsIBA 01/2021 - 12/2020
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2020 - 11/2017
2	Immune Checkpoint InhibitorsIBA 10/2020 - 01/2020
2	Estrogen ReceptorsIBA 04/2020 - 01/2020
2	human ERBB2 proteinIBA 04/2020 - 01/2020
2	regorafenibIBA 01/2019 - 01/2018
2	Imatinib Mesylate (Gleevec)FDA Link 06/2018 - 01/2018
2	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2018 - 07/2016
2	Messenger RNA (mRNA)IBA 01/2018 - 07/2006
2	Cyclin-Dependent Kinase 4IBA 11/2017 - 07/2016
2	Insulin (Novolin)FDA Link 11/2017 - 07/2016
2	EndotoxinsIBA 02/2017 - 02/2014
2	Thymidylate SynthaseIBA 01/2017 - 07/2006
2	Equilibrative Nucleoside Transporter 1IBA 01/2017 - 05/2007
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2017 - 07/2006
2	Fluorouracil (Carac)FDA LinkGeneric 12/2013 - 07/2006
2	Small Interfering RNA (siRNA)IBA 12/2013 - 05/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2013 - 05/2012
2	Complementary DNA (cDNA)IBA 07/2011 - 07/2006
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2023
1	Hemoglobins (Hemoglobin)IBA 02/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022
1	Hormones (Hormone)IBA 02/2022
1	Calcibiotic Root Canal SealerIBA 01/2022

Therapy/Procedure

28	Therapeutics 02/2024 - 02/2006
27	Neoadjuvant Therapy 04/2023 - 01/2014
23	Drug Therapy (Chemotherapy) 06/2024 - 07/2006
16	Hepatectomy 02/2024 - 11/2007
7	Pancreaticoduodenectomy 01/2021 - 01/2014
6	Stents 07/2021 - 12/2012
5	Liver Transplantation 03/2021 - 12/2012
4	Radiotherapy 04/2023 - 08/2019
4	Pancreatectomy 01/2023 - 08/2019
4	Adjuvant Chemotherapy 05/2022 - 08/2016
4	Transplantation 05/2016 - 05/2012
3	Oral Administration 06/2018 - 01/2018
2	Length of Stay 01/2023 - 10/2013
2	Absorbable Gelatin Sponge 12/2020 - 01/2014
2	Immunotherapy 05/2020 - 09/2017
2	Lymph Node Excision (Lymph Node Dissection) 09/2019 - 12/2015
2	Laparotomy 06/2018 - 01/2018
1	Chemoradiotherapy 06/2024
1	Subcutaneous Injections 02/2022